Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

LEVOFLOXACIN

LEVOFLOXACIN; SODIUM CHLORIDE

Standard Dose
5MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview LEVOFLOXACIN is listed in Drugs@FDA under application 021832 (NDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient LEVOFLOXACIN; SODIUM CHLORIDE Form and strength INJECTABLE; INJECTION - 5MG/ML Sponsor SICOR PHARMS Submission history Latest submission status date: 2005-06-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOFLOXACIN is listed in Drugs@FDA under application 021832 (NDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient LEVOFLOXACIN; SODIUM CHLORIDE Form and strength INJECTABLE; INJECTION - 5MG/ML Sponsor SICOR PHARMS Submission history Latest submission status date: 2005-06-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.